Year 8, Number 31, January 2006

 

Endocrinología, Terapia y Miscelánea
Article N°AJ31-21

 

 


Vivante, H.[1]; Salgueiro, MJ.[2]; Nicolini, M.[1]; Ughetti, R.[1]; Nicolini, J.[1] and Zubillaga, MB.[2]

[1]Bacon Laboratories SAIC.
[2]Radioisotope Laboratory, Physics Department, School of Pharmacy and Biochemistry, University of Buenos Aires. Buenos Aires, Argentina e-mail mariano@bacon.com.ar

Cita/Reference:
Vivante, H.; Salgueiro, MJ.; Nicolini, M. et al. Evaluation of a 32P-patch (Silibraq®) in the management of keloids which have recurred after several previous treatments: a case report. Alasbimn Journal 8(31): January 2006.



Evaluation of a 32P-patch (Silibraq®) in the management of keloids which have recurred after several previous treatments: a case report


Keloids are the result of excessive fibroblast proliferation and then over-abundant collagen deposition. In spite of the several treatment modalities available, there is no method able to guarantee absolute success in the therapeutic approach to keloids.The use of radiotherapy (teletherapy and brachytherapy) after surgery is well documented and results are promissory. Our case report involves a female patient with three lesions in her back (Q1, Q2 and Q3) and another one in the posterior neck behind the ear (Qra), treated with a silicon patch with 32P (Silibraq®). Pre-treatment and adjuvant treatment of the lesions were performed with Thiomucase, 5-fluoruracile, procaine and triamcinolone. Measurements of the lesions were taken and the patch was specially designed for its application on each lesion surface with minimal contact with the normal surrounding tissue. Taking into account the activity contained in each of the patches and the total radiation dose to administer according to clinical practice, dosimetric calculations were done for each lesion using the following equation:

 

D (o) =
œ As x Ēβ x 1.6 10-6 erg/Mev x 3.7 1010 des/seg Ci
________________________________________
Rβx δx 100 erg/g Rad

As s: activity per surface.
Ēβ: median β energy.
Rβ: maximum range.
δ: tissue density (assumed as water = 1g/cm3).

All keloid scars were controlled at 2 months of follow-up. Q1 has total remission within 2 months of treatment. Last follow-up visit (6 months after therapy) revealed that Q2 achieved a partial remission by reducing its size up to 80% and Q3 achieved total remission. Qra reduced its size up to 50% of the original within 1 week after therapy with 32P and a partial a partial remission of 70% was achieved 2 weeks after patch application. Erythema and hyperpigmentation developed after the treatment of the keloids but were successfully controlled.This case report confirms the efficacy of this modality treatment of keloids. Total remission was achieved in two treated lesions within 2 and 6 months of follow-up and the other two lesions resulted in 70-80% reduction of their size within 6 and 2 months, respectively.

 


Comparison of 99mTc-pertecnetate thyroid uptake at 20 minutes and 123I-iodide thyroid uptake at 2 and 24 hours | Estudio comparativo entre la gammagrafía con 111In-DTPAOC y la Tomografía Computerizada en la estadificación de tumores neuroendócrinos gastroenteropancreáticos | Há atordoamento (stunning) no tratamento do bócio difuso tóxico? | Valoración de la eficacia de la corticoterapia en el tratamiento del exoftalmo en el hipertiroidismo | Cintigrama de paratiroides con Tc-99m MIBI SPECT precoz: utilidad en el diagnóstico de localización de Hiperparatiroidismo Primario | Evaluación de 15 años de Pesquisa Neonatal de Hipotiroidismo en Uruguay. Resultados de una encuesta a 245 casos diagnosticados. | Dosimetría de I-131: Cuantificación de la actividad y el volumen en metastásis de Cancer Diferenciado de Tiroides | Utilidad del rastreo corporal total con Tc-99m sestamibi en el seguimiento del cáncer diferenciado de tiroides | The Value of Diagnostic Whole Body Scans with Iodine-131 (DxWBS) after recombinant humanTSH (rhTSH) for the follow-up of patients with Differentiated Thyroid Carcinoma | Utilidad del rastreo con MIBI – Tc99m en la localización de glándulas paratiroides hiperfuncionantes | Diagnóstico mediante técnicas de Medicina Nuclear de un foco comunitario de hipertiroidismo transitorio | Parathyroid scintigraphy: blinded comparison of 15 minutes, 2 hours and 6 hours images | Five different images of thyroid gland in results at three months Grave’s disease treated with I-131 | Evaluación clínica y de seguridad radiológica de un tratamiento con 188Re-Sn en pacientes con hemartrosis o con artritis reumatoidea | Evaluation of a 32P-patch (Silibraq®) in the management of keloids which have recurred after several previous treatments: a case report | Estrategia para el cuidado integral del paciente con enfermedad metastásica ósea | Evaluación radioisotópica de la respuesta a la toxina botulínica Tipo-A en sialorrea asociada a enfermedades neurológicas | Alteraciones distintas a Reflujo Vésico Ureteral en estudio radiológico de pacientes con infección del Tracto Urinario | Captación de 99mTc-MIBI en tejido adiposo pardo: comunicación de dos casos | Valor de la perfusión pulmonar en niños portadores de enfermedad respiratoria crónica oxigeno-dependientes | Clinical usefulness of SPECT/CT fusion with external markers in oncology pathology. | Valor pronóstico de la detección de marcadores moleculares en sangre periférica y del centellograma con 99mTc MIBI en pacientes con melanoma en seguimiento clínico: resultados preliminares | 99mTc-cysteine-glucosamine in the evaluation of patients with malignancy and histopathologic correlation | Utilidad de la gammagrafía con Galio 67 en el seguimiento de pacientes con Linfoma | 99mTc Glucarato como trazador tumoral en pacientes portadores de cáncer de pulmón y de mama | Utilidade da cintilografia de mamas com sestamibi[99mTc] como determinante de recidiva locorregional óssea de carcinoma mamário. Relato de caso | Print

 

 

Sitio desarrollado por SISIB - Universidad de Chile